Neutral polymeric micelles for RNA delivery

Bioconjugate Chemistry

Volumn 24, Issue 3, 2013, Pages 398-407

  Lundy, Brittany B ^a   Convertine, Anthony ^a   Miteva, Martina ^a   Stayton, Patrick S ^a  

^a University of Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BLOCK COPOLYMERS; BLOOD; CONTROLLED DRUG DELIVERY; CRITICAL MICELLE CONCENTRATION; DYNAMIC LIGHT SCATTERING; FREE RADICAL POLYMERIZATION; HYDROPHILICITY; LANTHANUM COMPOUNDS; PROTEINS; RNA; SULFUR COMPOUNDS; TARGETED DRUG DELIVERY; TOXICITY;

BUTYL METHACRYLATES; CONDITION; DELIVERY SYSTEMS; DIBLOCK-COPOLYMER; DIMETHYLAMINOETHYL METHACRYLATES; HYDROPHILICS; METHACRYLAMIDES; POLYMERIC MICELLE; RNA INTERFERENCE; THERAPEUTIC POTENTIALS;

MICELLES;

DIBLOCK COPOLYMER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; POLYMER; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL PH; CHEMICAL COMPOSITION; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DRUG CONJUGATION; FEMALE; GEL ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; GENE SILENCING; GENE TARGETING; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; LIGHT SCATTERING; MICELLE; MOLECULAR WEIGHT; NONVIRAL GENE DELIVERY SYSTEM; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

PAA;

EID: 84875412083     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300486k     Document Type: Article

References (53)

1. Shim, M. S. and Kwon, Y. J. (2010) Efficient and targeted delivery of siRNA in vivo FEBS J. 277, 4814-4827
2. Aliabadi, H. M., Landry, B., Sun, C., Tang, T., and UludagÌ, H. (2012) Supramolecular assemblies in functional siRNA delivery: Where do we stand? Biomaterials 33, 2546-2569
3. Whitehead, K. A., Langer, R., and Anderson, D. G. (2009) Knocking down barriers: advances in siRNA delivery Nat. Rev. Drug Discovery 8, 129-138
4. Guo, P., Coban, O., Snead, N. M., Trebley, J., Hoeprich, S., Guo, S., and Shu, Y. (2010) Engineering RNA for targeted siRNA delivery and medical application Adv. Drug Delivery Rev. 62, 650-666
5. Landen, C., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M., Lopez-Berestein, G., and Sood, A. (2005) Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery Cancer Res. 65, 6910-6918
6. Tran, M. A., Watts, R. J., and Robertson, G. P. (2009) Use of liposomes as drug delivery vehicles for treatment of melanoma Pigm. Cell Melanoma Res. 22, 388-399
7. Villares, G. J. G., Zigler, M. M., Wang, H. H., Melnikova, V. O. V., Wu, H. H., Friedman, R. R., Leslie, M. C. M., Vivas-Mejia, P. E. P., Lopez-Berestein, G. G., Sood, A. K. A., and Bar-Eli, M. M. (2008) Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA CORD Conf. Proc. 68, 9078-9086
8. Halder, J. J., Kamat, A. A. A., Landen, C. N. C., Han, L. Y. L., Lutgendorf, S. K. S., Lin, Y. G. Y., Merritt, W. M. W., Jennings, N. B. N., Chavez-Reyes, A. A., Coleman, R. L. R., Gershenson, D. M. D., Schmandt, R. R., Cole, S. W. S., Lopez-Berestein, G. G., and Sood, A. K. A. (2006) Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy Clin. Cancer Res. 12, 4916-4924
9. Sato, A., Takagi, M., Shimamoto, A., Kawakami, S., and Hashida, M. (2007) Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice Biomaterials 28, 1434-1442
10. Chien, P.-Y. P., Wang, J. J., Carbonaro, D. D., Lei, S. S., Miller, B. B., Sheikh, S. S., Ali, S. M. S., Ahmad, M. U. M., and Ahmad, I. I. (2005) Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo Cancer Gene Ther. 12, 321-328
11. Pal, A. A., Ahmad, A. A., Khan, S. S., Sakabe, I. I., Zhang, C. C., Kasid, U. N. U., and Ahmad, I. I. (2005) Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer Int. J. Oncol. 26, 1087-1091
12. Basha, G., Novobrantseva, T. I., Rosin, N., Tam, Y. Y. C., Hafez, I. M., Wong, M. K., Sugo, T., Ruda, V. M., Qin, J., Klebanov, B., Ciufolini, M., Akinc, A., Tam, Y. K., Hope, M. J., and Cullis, P. R. (2011) Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells Mol. Ther. 19, 2186-2200
13. Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., Hafez, I. M., Dorkin, J. R., Qin, J., Lam, K., Rajeev, K. G., Wong, K. F., Jeffs, L. B., Nechev, L., Eisenhardt, M. L., Jayaraman, M., Kazem, M., Maier, M. A., Srinivasulu, M., Weinstein, M. J., Chen, Q., Alvarez, R., Barros, S. A., De, S., Klimuk, S. K., Borland, T., Kosovrasti, V., Cantley, W. L., Tam, Y. K., Manoharan, M., Ciufolini, M. A., Tracy, M. A., de Fougerolles, A., MacLachlan, I., Cullis, P. R., Madden, T. D., and Hope, M. J. (2010) Rational design of cationic lipids for siRNA delivery Nat. Biotechnol. 28, 172-176
14. Huang, Y.-H., Bao, Y., Peng, W., Goldberg, M., Love, K., Bumcrot, D. A., Cole, G., Langer, R., Anderson, D. G., and Sawicki, J. A. (2009) Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis Proc. Natl. Acad. Sci. U.S.A. 106, 3426-3430
15. Leuschner, F. F., Dutta, P. P., Gorbatov, R. R., Novobrantseva, T. I. T., Donahoe, J. S. J., Courties, G. G., Lee, K. M. K., Kim, J. I. J., Markmann, J. F. J., Marinelli, B. B., Panizzi, P. P., Lee, W. W. W., Iwamoto, Y. Y., Milstein, S. S., Epstein-Barash, H. H., Cantley, W. W., Wong, J. J., Cortez-Retamozo, V. V., Newton, A. A., Love, K. K., Libby, P. P., Pittet, M. J. M., Swirski, F. K. F., Koteliansky, V. V., Langer, R. R., Weissleder, R. R., Anderson, D. G. D., and Nahrendorf, M. M. (2011) Therapeutic siRNA silencing in inflammatory monocytes in mice Nat. Biotechnol. 29, 1005-1010
16. Hashida, M., Kawakami, S., and Yamashita, F. (2005) Lipid carrier systems for targeted drug and gene delivery Chem. Pharm. Bull. (Tokyo) 53, 871-880
17. Mahon, K. P., Love, K. T., Whitehead, K. A., Qin, J., Akinc, A., Leshchiner, E., Leshchiner, I., Langer, R., and Anderson, D. G. (2010) Combinatorial approach to determine functional group effects on lipidoid-mediated siRNA delivery Bioconjugate Chem. 21, 1448-1454
18. Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Glud, S. Z., Andersen, M. O., Hovgaard, M. B., Schmitz, A., Nyengaard, J. R., Besenbacher, F., and Kjems, J. (2006) RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system Mol. Ther. 14, 476-484
19. Howard, K. A., Paludan, S. R., Behlke, M. A., Besenbacher, F., Deleuran, B., and Kjems, J. (2009) Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model CORD Conf. Proc. 17, 162-168
20. Sarmento, B. and das Neves, J., Eds. (2012) Chitosan-Based Systems for Biopharmaceuticals, p 592, Wiley, Chichester, U.K.
21. Pillé, J.-Y. J., Li, H. H., Blot, E. E., Bertrand, J.-R. J., Pritchard, L.-L. L., Opolon, P. P., Maksimenko, A. A., Lu, H. H., Vannier, J.-P. J., Soria, J. J., Malvy, C. C., and Soria, C. C. (2006) Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer Hum. Gene Ther. 17, 1019-1026
22. Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., and Davis, M. E. (2007) Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA Proc. Natl. Acad. Sci. U.S.A. 104, 5715-5721
23. Wightman, L. L., Kircheis, R. R., Rössler, V. V., Carotta, S. S., Ruzicka, R. R., Kursa, M. M., and Wagner, E. E. (2001) Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo J. Gene Med. 3, 362-372
24. Wang, Y., Li, Z., Han, Y., Liang, L. H., and Ji, A. (2010) Nanoparticle-based delivery system for application of siRNA in vivo Curr. Drug Metab. 11, 182-196
25. Kim, I.-D., Lim, C.-M., Kim, J.-B., Nam, H. Y., Nam, K., Kim, S.-W., Park, J.-S., and Lee, J.-K. (2010) Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain J. Controlled Release 142, 422-430
26. Watanabe, K., Harada-Shiba, M., Suzuki, A., Gokuden, R., Kurihara, R., Sugao, Y., Mori, T., Katayama, Y., and Niidome, T. (2009) In vivo siRNA delivery with dendritic poly(l -lysine) for the treatment of hypercholesterolemia Mol. BioSyst. 5, 1306-1310
27. Khan, A., Benboubetra, M., Sayyed, P. Z., Ng, K. W., Fox, S., Beck, G., Benter, I. F., and Akhtar, S. (2004) Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies J. Drug Targeting 12, 393-404
28. Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., John, M., Kesavan, V., Lavine, G., Pandey, R. K., Racie, T., Rajeev, K. G., Röhl, I., Toudjarska, I., Wang, G., Wuschko, S., Bumcrot, D., Koteliansky, V., Limmer, S., Manoharan, M., and Vornlocher, H.-P. (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs Nature 432, 173-178
29. Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., Zimmermann, T., Koteliansky, V., Manoharan, M., and Stoffel, M. (2007) Mechanisms and optimization of in vivo delivery of lipophilic siRNAs Nature 25, 1149-1157
30. Musacchio, T., Vaze, O., D'Souza, G., and Torchilin, V. P. (2010) Effective stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles Bioconjugate Chem. 21, 1530-1536
31. Lorenz, C., Hadwiger, P., John, M., Vornlocher, H. P., and Unverzagt, C. (2004) Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells Bioorg. Med. Chem. Lett. 14, 4975-4977
32. Nishina, K., Unno, T., Uno, Y., Kubodera, T., Kanouchi, T., Mizusawa, H., and Yokota, T. (2008) Efficient in vivo delivery of siRNA to the liver by conjugation of α-tocopherol Mol. Ther. 16, 734-740
33. Chiu, Y.-L., Ali, A., Chu, C.-Y., Cao, H., and Rana, T. M. (2004) Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells Chem. Biol. 11, 1165-1175
34. Moschos, S. A. S., Jones, S. W. S., Perry, M. M. M., Williams, A. E. A., Erjefalt, J. S. J., Turner, J. J. J., Barnes, P. J. P., Sproat, B. S. B., Gait, M. J. M., and Lindsay, M. A. M. (2007) Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity Bioconjugate Chem. 18, 1450-1459
35. Muratovska, A. and Eccles, M. R. (2004) Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells FEBS Lett. 558, 63-68
36. Gunasekaran, K., Nguyen, T. H., Maynard, H. D., Davis, T. P., and Bulmus, V. (2011) Conjugation of siRNA with comb-type PEG enhances serum stability and gene silencing efficiency Macromol. Rapid Commun. 32, 654-659
37. Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., and Park, T. G. (2006) PEG conjugated VEGF siRNA for anti-angiogenic gene therapy J. Controlled Release 116, 123-129
38. Rozema, D. B., Lewis, D. L., Wakefield, D. H., Wong, S. C., Klein, J. J., Roesch, P. L., Bertin, S. L., Reppen, T. W., Chu, Q., Blokhin, A. V., Hagstrom, J. E., and Wolff, J. A. (2007) Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes Proc. Natl. Acad. Sci. U.S.A. 104, 12982-12987
39. Lee, S. H., Mok, H., and Park, T. G. (2010) Di-and triblock siRNA-PEG copolymers: PEG density effect of polyelectrolyte complexes on cellular uptake and gene silencing efficiency Macromol. Biosci. 11, 410-418
40. Choi, S. W., Lee, S. H., Mok, H., and Park, T. G. (2010) Multifunctional siRNA delivery system: polyelectrolyte complex micelles of six-arm PEG conjugate of siRNA and cell penetrating peptide with crosslinked fusogenic peptide Biotechnol. Prog. 26, 57-63
41. Heredia, K. L., Nguyen, T. H., Chang, C.-W., Bulmus, V., Davis, T. P., and Maynard, H. D. (2008) Reversible siRNA-polymer conjugates by RAFT polymerization Chem. Commun. (Cambridge, U. K.) 3245-3247
42. Xu, J., Boyer, C., Bulmus, V., and Davis, T. P. (2009) Synthesis of dendritic carbohydrate end-functional polymers via RAFT: versatile multi-functional precursors for bioconjugations J. Polym. Sci., Part A: Polym. Chem. 47, 4302-4313
43. Convertine, A. J., Benoit, D. S. W., Duvall, C. L., Hoffman, A. S., and Stayton, P. S. (2009) Development of a novel endosomolytic diblock copolymer for siRNA delivery J. Controlled Release 133, 221-229
44. Convertine, A. J., Diab, C., Prieve, M., Paschal, A., Hoffman, A. S., Johnson, P. H., and Stayton, P. S. (2010) pH-Responsive Polymeric Micelle Carriers for siRNA Drugs Biomacromolecules 11, 2904-2911
45. Benoit, D. S. W., Henry, S. M., Shubin, A. D., Hoffman, A. S., and Stayton, P. S. (2010) pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1 Mol. Pharmaceutics 7, 442-455
46. Palanca-Wessels, M. C., Convertine, A. J., Cutler-Strom, R., Booth, G. C., Lee, F., Berguig, G. Y., Stayton, P. S., and Press, O. W. (2011) Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells Mol. Ther. 19, 1529-1537
47. Crownover, E., Duvall, C. L., Convertine, A., Hoffman, A. S., and Stayton, P. S. (2011) RAFT-synthesized graft copolymers that enhance pH-dependent membrane destabilization and protein circulation times J. Controlled Release 155, 167-174
48. Crownover, E. F., Convertine, A. J., and Stayton, P. S. (2011) pH-responsive polymer-antigen vaccine bioconjugates Polym. Chem. 2, 1499-1504
49. Scales, C., Vasilieva, Y., Convertine, A., Lowe, A., and McCormick, C. (2005) Direct, controlled synthesis of the nonimmunogenic, hydrophilic polymer, poly(N -(2-hydroxypropyl)methacrylamide) via RAFT in aqueous media Biomacromolecules 6, 1846-1850
50. Scales, C. W., Huang, F., Li, N., Vasilieva, Y. A., Ray, J., Convertine, A. J., and McCormick, C. L. (2006) Corona-stabilized interpolyelectrolyte complexes of SiRNA with nonimmunogenic, hydrophilic/cationic block copolymers prepared by aqueous RAFT polymerization Macromolecules 39, 6871-6881
51. Xie, F., Woodle, M., and Lu, P. (2006) Harnessing in vivo siRNA delivery for drug discovery and therapeutic development Drug Discovery Today 11, 67-73
52. Torchilin, V. (2005) Recent advances with liposomes as pharmaceutical carriers Nat. Rev Drug Discovery 4, 145-160
53. Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., and Blumenthal, R. (2009) Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic Crit. Rev. Ther. Drug Carrier Syst. 26, 523-580